LY2140023 Completed Phase 1 Trials for Schizophrenia Other

IndicationsStatusPurposePhase
CompletedOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT01354353A Study of Safety and Tolerability in Subjects With Schizophrenia